• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在人体内,苯巴比妥和非诺洛芬(一种新型抗炎药)之间存在药代动力学相互作用。

A pharmacokinetic interaction in man between phenobarbitone and fenoprofen, a new anti-inflammatory agent.

机构信息

Lilly Laboratory for Clinical Research, 960 Locke Street, Indianapolis, Indiana, U.S.A.

出版信息

Br J Clin Pharmacol. 1974 Oct;1(5):371-4. doi: 10.1111/j.1365-2125.1974.tb00271.x.

DOI:10.1111/j.1365-2125.1974.tb00271.x
PMID:22454912
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1402462/
Abstract

1 The effect of repeated administration of phenobarbitone on the plasma disposition of fenoprofen (±-2-(3-phenoxyphenyl) propionic acid) was investigated in rats and man. 2 The plasma elimination rate constants increased significantly and the rats excreted proportionately more metabolized fenoprofen in the urine. These findings are consistent with an increase in the rate of metabolism of fenoprofen. 3 This interaction between phenobarbitone (and presumably other inducers of drug metabolizing enzymes) and fenoprofen should be considered when evaluating the clinical usefulness of fenoprofen.

摘要
  1. 重复给予苯巴比妥对人体和大鼠体内芬布芬(±-2-(3-苯氧苯基)丙酸)的血浆处置的影响进行了研究。

  2. 血浆消除速率常数显著增加,大鼠尿液中代谢的芬布芬比例增加。这些发现与芬布芬代谢率的增加一致。

  3. 在评估芬布芬的临床用途时,应考虑苯巴比妥(以及可能其他药物代谢酶诱导剂)与芬布芬之间的这种相互作用。

相似文献

1
A pharmacokinetic interaction in man between phenobarbitone and fenoprofen, a new anti-inflammatory agent.在人体内,苯巴比妥和非诺洛芬(一种新型抗炎药)之间存在药代动力学相互作用。
Br J Clin Pharmacol. 1974 Oct;1(5):371-4. doi: 10.1111/j.1365-2125.1974.tb00271.x.
2
Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. III. Fenoprofen disposition.2-芳基丙酸类非甾体抗炎药的对映体选择性处置。III. 非诺洛芬的处置
J Pharmacol Exp Ther. 1987 Feb;240(2):631-6.
3
Disposition of human drug preparations in the horse. IV. Orally administered fenoprofen.人用药物制剂在马体内的处置。IV. 口服非诺洛芬。
J Pharm Biomed Anal. 1995 Jul;13(8):1041-7. doi: 10.1016/0731-7085(95)01512-j.
4
Enantioselective kinetic disposition of fenoprofen in rats with experimental diabetes or adjuvant-induced arthritis.非诺洛芬在实验性糖尿病或佐剂诱导性关节炎大鼠中的对映体选择性动力学处置
Pharmacology. 2004 Oct;72(2):85-91. doi: 10.1159/000079136.
5
Ocular anti-inflammatory effect of fenoprofen. Dose-response study.非诺洛芬的眼部抗炎作用。剂量反应研究。
Arch Ophthalmol. 1975 Jul;93(7):501-3. doi: 10.1001/archopht.1975.01010020517006.
6
High-performance liquid chromatographic assay for fenoprofen in human plasma.人血浆中苯氧布洛芬的高效液相色谱测定法。
J Pharm Sci. 1981 May;70(5):507-9. doi: 10.1002/jps.2600700511.
7
Fenoprofen: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases.非诺洛芬:其药理特性及在风湿性疾病中治疗效果的综述
Drugs. 1977 Apr;13(4):241-65. doi: 10.2165/00003495-197713040-00001.
8
Linear pharmacokinetics of orally administered fenoprofen calcium.口服芬诺洛芬钙的线性药代动力学。
J Pharm Sci. 1979 Sep;68(9):1087-90. doi: 10.1002/jps.2600680907.
9
Quantification of fenoprofen in human plasma using UHPLC-tandem mass spectrometry for pharmacokinetic study in healthy subjects.采用超高效液相色谱-串联质谱法对人血浆中的非诺洛芬进行定量分析,用于健康受试者的药代动力学研究。
Biomed Chromatogr. 2020 Jan;34(1):e4708. doi: 10.1002/bmc.4708. Epub 2019 Nov 10.
10
Influence of rheumatoid arthritis in the enantioselective disposition of fenoprofen.类风湿关节炎对非诺洛芬对映体选择性处置的影响。
Chirality. 2004 Nov;16(9):602-8. doi: 10.1002/chir.20065.

引用本文的文献

1
Pharmacokinetic interactions with antiepileptic drugs.与抗癫痫药物的药代动力学相互作用。
Clin Pharmacokinet. 1982 Jan-Feb;7(1):57-84. doi: 10.2165/00003088-198207010-00004.
2
Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs.非甾体抗炎药的临床药代动力学
Clin Pharmacokinet. 1983 Jul-Aug;8(4):297-331. doi: 10.2165/00003088-198308040-00003.
3
Clinical implications of enzyme induction and enzyme inhibition.酶诱导和酶抑制的临床意义。
Clin Pharmacokinet. 1981 Jan-Feb;6(1):1-24. doi: 10.2165/00003088-198106010-00001.
4
Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.非甾体抗炎药的药代动力学药物相互作用。
Clin Pharmacokinet. 1990 Jul;19(1):44-66. doi: 10.2165/00003088-199019010-00004.
5
Clinical pharmacokinetics of drugs used in juvenile arthritis.青少年关节炎用药的临床药代动力学
Clin Pharmacokinet. 1991 Aug;21(2):129-49. doi: 10.2165/00003088-199121020-00004.
6
Fenoprofen: a review of its pharmacological properties and therapeutic efficacy in rheumatic diseases.非诺洛芬:其药理特性及在风湿性疾病中治疗效果的综述
Drugs. 1977 Apr;13(4):241-65. doi: 10.2165/00003495-197713040-00001.

本文引用的文献

1
Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.苯巴比妥诱导人体血浆安替比林半衰期缩短的遗传控制。
J Clin Invest. 1969 Dec;48(12):2202-9. doi: 10.1172/JCI106186.
2
Physiological disposition of fenoprofen in man. I. Pharmacokinetic comparison of calcium and sodium salts administered orally.
J Pharm Sci. 1971 Dec;60(12):1797-801. doi: 10.1002/jps.2600601205.
3
GLC determination of dl-2-(3-phenoxyphenyl)propionic acid (Fenoprofen) in human plasma.用气相色谱法测定人血浆中消旋2-(3-苯氧基苯基)丙酸(非诺洛芬)的含量。
J Pharm Sci. 1971 Jul;60(7):1062-4. doi: 10.1002/jps.2600600713.
4
Physiological disposition of fenoprofen in man. II. Plasma and urine pharmacokinetics after oral and intravenous administration.
J Pharm Sci. 1972 May;61(5):739-45. doi: 10.1002/jps.2600610514.